TY - JOUR
T1 - Neuropsychiatric symptoms in patients with possible vascular cognitive impairment, does sex matter?
AU - Exalto, L G
AU - Boomsma, J M
AU - Sep, Ycp
AU - Leeuwis, A E
AU - Scheltens, P
AU - Biessels, G J
AU - van der Flier, W M
N1 - Funding Information:
Research of the Alzheimer center Amsterdam is part of the neurodegeneration research program of the Amsterdam Neuroscience. Alzheimer center Amsterdam is supported by Stichting Alzheimer Nederland and Stichting VUMC fonds. The clinical database structure was developed with funding from Stichting Dioraphte. WF holds the Pasman chair. WF is recipient of is recipient of NCDC, which is funded in the context of Deltaplan Dementie from ZonMW Memorabel (projectnr 73305095005) and Alzheimer Nederland.
Funding Information:
LG Exalto is supported by Alzheimer Nederland WE.03–2019–15. The TRACE-VCI study was supported by Vidi grant 917.11.384 and Vici grand 918.16.616 from ZonMw, The Netherlands, organisation for Health Research and Development and grant 2010T073 from the Dutch Heart Association to Geert Jan Biessels. This work is also supported by the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation (CVON 2018–28 Heart Brain Connection).
Publisher Copyright:
© 2022
PY - 2022
Y1 - 2022
N2 - Background: Neuropsychiatric symptoms (NPS) are common in patients with vascular cognitive impairment (VCI). We aimed to establish sex differences in the manifestation of NPS in memory clinic patients with possible VCI and identify which NPS are determinants of clinical progression in women and men separately.Methods: We included 718 memory clinic patients (age 68 ± 8; 45% women) with cognitive complaints and vascular brain lesions on MRI (i.e. possible VCI). NPS were measured using the 12-item Neuropsychiatric Inventory. Clinical progression after two years (women 18%, men 14%) was defined as increase in CDR ≥1 or institutionalization (available
n = 589 without advanced dementia at baseline). The association between NPS and clinical progression was assessed with Cox proportional hazard models stratified by sex, adjusted for age and clinical diagnosis and in a second model additionally for manifestations of vascular brain lesions.
Results: Men more often presented with agitation (29% versus 17%,
p<.05) and irritability (58% versus 45%,
p<.05), the other 10 NPS (delusions, hallucinations, depression, anxiety, euphoria, apathy, disinhibition, aberrant motor behavior, nighttime disturbances and appetite & eating abnormalities) did not differ between sexes. In women the presence of apathy (HR 2.1[1.1;4.3]) was associated with higher risk of clinical progression. In men the presence of depression (HR 2.7[1.4;5.1]) and aberrant motor behavior (HR 2.1[1.1;3.8]) were associated with increased risk of clinical progression.
Conclusion: Manifestations of NPS in patients with possible VCI differ by sex. Different NPS are associated with future clinical progression in men and women. Management strategies of NPS could benefit from sex-specific approaches.
AB - Background: Neuropsychiatric symptoms (NPS) are common in patients with vascular cognitive impairment (VCI). We aimed to establish sex differences in the manifestation of NPS in memory clinic patients with possible VCI and identify which NPS are determinants of clinical progression in women and men separately.Methods: We included 718 memory clinic patients (age 68 ± 8; 45% women) with cognitive complaints and vascular brain lesions on MRI (i.e. possible VCI). NPS were measured using the 12-item Neuropsychiatric Inventory. Clinical progression after two years (women 18%, men 14%) was defined as increase in CDR ≥1 or institutionalization (available
n = 589 without advanced dementia at baseline). The association between NPS and clinical progression was assessed with Cox proportional hazard models stratified by sex, adjusted for age and clinical diagnosis and in a second model additionally for manifestations of vascular brain lesions.
Results: Men more often presented with agitation (29% versus 17%,
p<.05) and irritability (58% versus 45%,
p<.05), the other 10 NPS (delusions, hallucinations, depression, anxiety, euphoria, apathy, disinhibition, aberrant motor behavior, nighttime disturbances and appetite & eating abnormalities) did not differ between sexes. In women the presence of apathy (HR 2.1[1.1;4.3]) was associated with higher risk of clinical progression. In men the presence of depression (HR 2.7[1.4;5.1]) and aberrant motor behavior (HR 2.1[1.1;3.8]) were associated with increased risk of clinical progression.
Conclusion: Manifestations of NPS in patients with possible VCI differ by sex. Different NPS are associated with future clinical progression in men and women. Management strategies of NPS could benefit from sex-specific approaches.
KW - Cognitive deterioration
KW - Neuropsychiatric symptoms
KW - Sex differences
KW - Vascular cognitive impairment
UR - http://www.scopus.com/inward/record.url?scp=85139306022&partnerID=8YFLogxK
U2 - 10.1016/j.cccb.2022.100152
DO - 10.1016/j.cccb.2022.100152
M3 - Article
C2 - 36324391
SN - 2666-2450
VL - 3
JO - Cerebral Circulation - Cognition and Behavior
JF - Cerebral Circulation - Cognition and Behavior
M1 - 100152
ER -